Home
>
Stock Market
>
>
Piramal Pharma Ltd

Piramal Pharma Ltd share price and stock overview

Piramal Pharma Ltd (NSE: PPLPHARMA, BSE: 543635) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE0DK501011 and a face value of Rs 10. As of 26 October 2026, it trades at Rs (195.17) with a market capitalisation of Rs 25408.78 crore. Figures are live and subject to change.

Piramal Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

NSE BSE

195.17 4.10 (2.15%) upARrowC

As on: 26-Oct-2026 , 10:43 PM

Market Cap(₹Cr) 25408.78

Book Value(₹Cr) 61.1809785

BSE Code : 543635 NSE Symbol : PPLPHARMA EPS(TTM) : 5.82 ISIN Demat : INE0DK501011 P/E(TTM) : 32.79 Face Value(₹) : 10 Div & Yield % : 0

Today Market

Stock Performance

Today Market

Today's High

73,606.75

Todday's Low

72,514.57

Open at

72,990.04

Previous Close

73,123.83

Volumes

Avg Price

482.92

Historical Performance

News

16 Oct 26

Piramal Pharma to review quarterly results at board meeting on October 27, 2026

Piramal Pharma Limited will hold a board meeting on Tuesday, 27th October 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter and half year ended 30th September 2026, according to a regulatory filing.

30 Sep 26

Piramal Pharma appoints Viral Gandhi as CTO, effective October 1, 2026

Piramal Pharma Limited announced the appointment of Mr. Viral Gandhi as Chief Technology Officer and a Senior Management Personnel, effective October 1, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited on September 30, 2026.

30 Sep 26

Brian Guy will lead Piramal Critical Care as President and COO starting October 19, 2026

Piramal Pharma Limited announced that Jeffrey Hampton will retire as President and COO of Piramal Critical Care, effective November 27, 2026, and that Brian Guy has been appointed as President and COO of Piramal Critical Care, effective October 19, 2026.

29 Sep 26

Piramal Pharma shutters securities trading for insiders pending financial results in late 2026

Piramal Pharma Limited informed the BSE Limited and National Stock Exchange of India Limited that the trading window for dealing in securities of the company will be closed for all designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of the unaudited financial results for the half year ending September 30, 2026, with the date of the board meeting to approve the results to be communicated later.

Historical Prices

Share Price Chart

Historical Share Price

Date	Open Price (₹)	High Price(₹)	Low Price(₹)	Close Price(₹)	Total Volume	No of Trades	Net Turnover(₹)	NIFTY
26-10-26	190.00	195.75	188.52	195.17	1471129	26668	284800049.54	22753.20
23-10-26	194.00	194.91	185.02	191.07	2465513	50138	468105353.80	22600.00
22-10-26	190.51	196.35	188.22	194.99	2835616	50822	548253738.62	22687.65
21-10-26	194.95	199.50	189.60	191.19	3166061	49011	614112751.37	22811.35
19-10-26	197.00	201.73	193.81	194.44	1318209	28898	260213426.11	22888.95
16-10-26	194.95	198.75	193.60	197.73	2049052	40224	403822047.69	23146.15
15-10-26	193.50	196.39	192.62	194.43	2995160	25546	581923170.16	22997.35
14-10-26	195.35	196.70	192.76	193.94	1689308	49948	328446646.65	22622.70
13-10-26	196.40	197.00	191.41	196.01	1390936	33047	270124045.67	22721.95
12-10-26	197.29	199.50	194.80	196.66	1479408	21138	290885991.40	22363.35

12 3 ...

Fundamentals

Company Valuation

Market Cap (₹cr)

25408.78

PE Ratio

32.79

PB Ratio

3.12

Dividend Yield

ROE

8.98

ROCE

10.77

Book Value (₹)

61.1809785

Face Value (₹)

Share Holding Pattern

Category of Shareholder	No of Shares	% Share Holdings	Demat Shares	Share Holders

Promoter & Group

Foreign

Foreign (Promoter & Group) - Bodies Corporate	0	0.00	0	0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign)	0	0.00	0	0
Foreign Promoter(Institutional)	0	0.00	0	0
Promoter Others	0	0.00	0	0

Sub Total

0.00

Indian

Bodies Corporate-Indian (Promoter & Group)	91750276	6.89	91750276	3
Government(Central / State)-Indian (Promoter & Group)	0	0.00	0	0
Directors & their Relatives-Indian (Promoter & Group)	0	0.00	0	0
Financial Institutions / Banks-Indian (Promoter & Group)	0	0.00	0	0
Individuals / Hindu Undivided Family-Indian (Promoter & Group)	2570932	0.19	2570932	9
Partnership Firms-Indian (Promoter & Group)	0	0.00	0	0
Persons Acting in Concert	0	0.00	0	0
Trusts	369003464	27.72	369003464	5
Others	0	0.00	0	0

Sub Total

463324672

34.80

463324672

Total ShareHolding for Promoter & Group

463324672

34.80

463324672

Publice Share Holding

Institution

Government(Central / State)	2659	0.00	2659	2
Clearing Members	0	0.00	0	0
Corporate Bodies	0	0.00	0	0
Foreign Direct Investments	0	0.00	0	0
Financial Institutions / Banks	9868	0.00	9868	3
Foreign Bank	0	0.00	0	0
Foreign Bodies Corporate/OCBs/FBC	0	0.00	0	0
Foreign Collaborators	0	0.00	0	0
Foreign Institutional Investors	181743381	13.65	181743381	191
Foreign Venture Capital Investors	0	0.00	0	0
Foreign Institution Other	0	0.00	0	0
Insurance Companies	16432030	1.23	16432030	13
Mutual Funds / UTI	169259414	12.71	169259414	27
Individuals (Non-Resident / Foreign)	0	0.00	0	0
NSDL Intransit	0	0.00	0	0
Others	6552900	0.49	6552900	30
Trusts	0	0.00	0	0
Venture Capital Funds	0	0.00	0	0

Sub total

374000252

28.09

374000252

266

Non Institution

Bodies Corporate	21520081	1.62	21520081	1295
Clearing Members	880337	0.07	880337	73
Directors & their Relatives	274433	0.02	274433	1
Employees	0	0.00	0	0
Escrow Account	0	0.00	0	0
Foreign Corporate Bodies	17315548	1.30	17315548	2
Foreign Direct Investments	0	0.00	0	0
NRIs/Foreign Individuals/Foreign Nationals	15198159	1.14	15198159	6969
Foreign Non Institution Other	238663700	17.93	238663700	1
Hindu Undivided Families	5973399	0.45	5973399	5703
Indian Public	0	0.00	0	0
Individuals holding nominal share capital in excess of Rs. 1 lakh	48553692	3.65	48553692	711
Individuals holding nominal share capital up to Rs. 1 lakh	128100783	9.62	128100783	398038
Market Maker	0	0.00	0	0
NSDL Transit	0	0.00	0	0
Shares in transit	0	0.00	0	0
Societies	0	0.00	0	0
Trust & Foundation	28143	0.00	28143	11
Others	3214656	0.24	3214656	1

Sub Total

488759611

36.71

488759611

412911

Total Public Shareholding

862759863

64.80

862759863

413177

Total of Promoter & Public ShareHolding

1326084535

99.60

1326084535

413194

Shares held by Custodians and against which Depository Receipts have been issued

ADR	0	0.00	0	0
GDR	0	0.00	0	0
Other Custodians	5263595	0.40	5263595	3

Total Shares held by Custodians and against which Depository Receipts have been issued

5263595

0.40

5263595

Grand Total

1331348130

100.00

1331348130

413197

Financials (₹ in cr)

Consolidated Standalone

Year End	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Net Sales	8,869.08	9,151.18	8,171.16	7,081.55	6,559.10
OPM (%)	0.23	4.53	2.96	-1.60	7.62
OP	20.08	414.64	242.08	-113.19	500.06
Other Income	213.30	134.81	175.39	225.11	275.80
PBIDT	995.98	1,652.57	1,368.35	900.72	1,269.41
INTEREST	340.80	421.59	448.49	344.18	198.25
PBDT	655.18	1,230.98	919.86	556.54	1,071.16
PBT	-372.20	414.64	116.50	-127.11	469.90
EO	-196.14	0.00	-62.79	-6.96	-15.08
PBT after EO	-176.06	414.64	179.29	-120.15	484.98
TAXES	149.88	323.51	161.47	66.31	109.02
PAT	-325.94	91.13	17.82	-186.46	375.96
EPS	-2.46	0.68	0.14	-1.54	3.19
Raw Material	22.50	22.46	24.19	23.76	23.89
Power and Fuel	2.93	2.92	2.96	2.93	2.49
Employee Cost	27.24	25.21	24.84	26.78	24.22
Other Manufacturing Expenses	1.33	1.23	1.32	1.61	1.20
Selling and Administration Expenses	12.63	11.60	12.17	12.96	13.24
Miscellaneous Expenses	2.53	2.05	1.87	2.35	1.07
Revenue (Growth %)	-3.08	11.99	15.39	7.97	3.87
PBIDT (Growth %)	-39.73	20.77	51.92	-29.04	-23.42
PAT (Growth %)	-457.66	411.39	-109.56	-149.60	-54.98
PBIDT (Margin %)	11.23	18.06	16.75	12.72	19.35
PAT (Margin %)	-3.68	1.00	0.22	-2.63	5.73

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Share Capital	1327.16	1324.35	1322.95	1193.32	1185.91	994.60
Reserves Total	6813.97	6128.19	5389.12	4068.47	3937.21	3105.92
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.10
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	8141.13	7452.54	6712.07	5261.79	5123.12	4100.62
Secured Loans	420.86	1009.06	895.58	1312.68	1153.78	90.20
Unsecured Loans	365.39	234.12	281.11	336.47	10.69	84.06
Total Debt	786.25	1243.18	1176.69	1649.15	1164.47	174.26
Other Liabilities	94.31	48.56	32.23	25.56	12.91	6.59
Total Liabilities	9021.69	8744.28	7920.99	6936.50	6300.50	4281.47
APPLICATION OF FUNDS :
Gross Block	4575.04	4248.53	3766.97	3564.57	3225.28	2260.11
Less : Accumulated Depreciation	1539.18	1354.25	1154.81	962.70	786.30	633.30
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	3035.86	2894.28	2612.16	2601.87	2438.98	1626.81
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	221.11	327.30	533.24	416.57	405.16	121.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	3579.60	3105.31	1708.16	1746.99	1629.53	1591.52
Current Assets, Loans & Advances
Inventories	1873.39	1205.35	1153.04	818.61	535.51	420.88
Sundry Debtors	1405.84	1666.69	1331.38	909.56	989.22	839.75
Cash and Bank Balance	574.32	177.84	241.73	64.16	137.23	152.35
Loans and Advances	451.00	486.00	504.12	456.23	403.17	354.52
Total Current Assets	4304.55	3535.88	3230.27	2248.56	2065.13	1767.50
Less : Current Liabilities and Provisions
Current Liabilities	2416.16	1391.57	1348.42	872.54	845.87	1264.21
Provisions	46.08	42.85	84.83	39.21	53.31	40.57
Total Current Liabilities & Provisions	2462.24	1434.42	1433.25	911.75	899.18	1304.78
Net Current Assets	1842.31	2101.46	1797.02	1336.81	1165.95	462.72
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	72.28	56.50	49.17	33.87	12.37	1.13
Deferred Tax Liability	341.62	269.63	245.81	228.02	183.73	171.55
Net Deferred Tax	-269.34	-213.13	-196.64	-194.15	-171.36	-170.42
Other Assets	612.15	529.06	1467.05	1028.41	832.24	649.84
Total Assets	9021.69	8744.28	7920.99	6936.50	6300.50	4281.47
Contingent Liabilities	95.72	97.27	59.25	57.32	42.81	28.19

Cash Flow (₹ in cr)

Yearly Cash Flow	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Financing Activities	896.40	290.12	451.38	-61.74	-615.13
Investing Activities	-1,164.62	-435.05	-635.15	-551.96	-317.83
Net Cash Flow	-19.03	-73.41	174.52	-64.93	395.16
Operating Activities	249.19	71.52	358.29	548.77	1,328.12

Peers

Balance Sheet Financial Ratios Profit & Loss

Aarti Pharmalabs...

823.10

(+0.27%)

Accent Microcell...

662.25

(+11.77%)

Accretion Pharma...

186.00

(+2.14%)

Achyut Healthcar...

Advanced Enzyme ...

252.15

(+1.53%)

Akums Drugs & Ph...

686.60

(+2.63%)

Albert David Ltd

777.10

(+1.75%)

Alembic Pharmace...

766.40

(+0.83%)

Corporate Actions

Bonus Dividends Splits

Date	Corporate Action	Information
No Corporate Actions Announced

Board of Directors

Functional Directors

Nandini Piramal

Chairperson / Executive Director

Exec.

PDD

PETER D DEYOUNG

Executive Director & CEO

Exec.

Vivek Valsaraj

Executive Director & CFO

Exec.

Independent Directors

Nathalie Leitch

Independent Non Exe. Director

Ind.

Amit Jain

Non-Exec & Non-Independent Dir

Ind.

JMP

Jairaj Manohar Purandare

Independent Non Exe. Director

Ind.

Sridhar Gorthi

Independent Non Exe. Director

Ind.

Peter Stevenson

Independent Non Exe. Director

Ind.

VPR

Vibha Paul Rishi

Independent Non Exe. Director

Ind.

AMIT SONI

Independent Non Exe. Director

Ind.

Other Officials

Maneesh Sharma

Company Sec. & Compli. Officer

Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Piramal Pharma Ltd? −

Piramal Pharma Ltd trades on NSE under PPLPHARMA and on BSE under code 543635. The ISIN is INE0DK501011 and the face value is Rs 10.

What is the share price of Piramal Pharma Ltd today? +

As of 26 October 2026, Piramal Pharma Ltd trades at Rs 195.17, a change of 4.10 (2.15%) on the day. Prices are live and subject to change.

What is the market capitalisation of Piramal Pharma Ltd? +

As of 26 October 2026, Piramal Pharma Ltd has a market cap of about Rs 25408.78 crore. This figure is live and moves with the share price.

Is Piramal Pharma Ltd profitable? +

In March 2026, Piramal Pharma Ltd reported a profit after tax of Rs -325.94 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Piramal Pharma Ltd? +

: As of 26 October 2026, the PE (TTM) for Piramal Pharma Ltd is 32.79 and the price-to-book ratio is 3.12. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Piramal Pharma Ltd pay a dividend? +

As of 26 October 2026, the dividend yield for Piramal Pharma Ltd is 0%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Piramal Pharma Ltd? +

As of the latest disclosed pattern, promoters hold 34.80% of Piramal Pharma Ltd. Public shareholding is 64.80%, including mutual funds at 12.71% and foreign institutional investors at 13.65%.

What were the latest annual financials of Piramal Pharma Ltd? +

In March 2026, Piramal Pharma Ltd reported net sales of Rs 8,869.08 crore, revenue growth of -3.08%, and earnings per share of Rs -2.46.